Product Details for: Opdualag

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
240MG, 80MG/20ML (12MG, 4MG/ML)
Single-Dose Vial
351(a)
Opdualag
Rx
Proper Name
nivolumab and relatlimab-rmbw
BLA Number
761234
Applicant
Bristol-Myers Squibb Company
Original Approval Date
March 18, 2022
Date of First Licensure
RETURN TO SEARCH RESULTS